Form 4: Amphastar Pharmaceuticals Executive Exercises Options and Sells Shares

A Form 4 filing reveals that a senior executive at Amphastar Pharmaceuticals exercised stock options and sold shares on November 12, 2024.

Summary

• On November 12, 2024, Rong Zhou, a Senior EVP at Amphastar Pharmaceuticals, exercised 6,893 stock options at a price of $14.95 per share.
• Following the exercise of options, Mr. Zhou sold 6,893 shares of common stock at a price of $48.88 per share.
• After these transactions, Mr. Zhou directly owns 118,388 shares of Amphastar common stock.
• Mr. Zhou also indirectly owns 99,668 shares through the Zhou Family Trust and 5,000 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider trading activity, with no indication of positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
• The transactions are typical for executives who receive stock options as part of their compensation packages.
• The exercise and sale of shares are within the normal range of insider trading activity.

Stakeholder Impact

• The transactions may have a minor impact on the stock price, but are unlikely to significantly affect stakeholders.

Key Dates

Keywords

Form 4, insider trading, stock options, share sale, Amphastar Pharmaceuticals, AMPH, Rong Zhou, executive compensation